
Releases
Erasca Faces Securities Fraud Class Action Over ERAS-0015 Data
Investors who purchased Erasca, Inc. securities between January 14, 2025, and April 26, 2026, face an August 10, 2026, deadline to join a class action lawsuit. The litigation, led by Schall Brown & Schwartz LLP, alleges the company misled the market regarding the clinical viability of its ERAS-0015 program.






















